img

Global Prophylactic Human Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Prophylactic Human Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Vaccination in the body of a healthy person causes the person to produce antibodies and obtain specific immunity in the absence of disease. For example, BCG vaccination, smallpox vaccination and so on.
Prophylactic Human Vaccine report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Prophylactic Human Vaccine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Scientific Research are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Prophylactic Human Vaccine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Prophylactic Human Vaccine key manufacturers include GSK, Biovac, McKesson Medical, Merck, Merial, Zoetis and Sanofi, etc. GSK, Biovac, McKesson Medical are top 3 players and held % sales share in total in 2022.
Prophylactic Human Vaccine can be divided into Inactivated Vaccine, Attenuated Vaccine and Others,, etc. Inactivated Vaccine is the mainstream product in the market, accounting for % sales share globally in 2022.
Prophylactic Human Vaccine is widely used in various fields, such as Hospital, Scientific Research and Others,, etc. Hospital provides greatest supports to the Prophylactic Human Vaccine industry development. In 2022, global % sales of Prophylactic Human Vaccine went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Prophylactic Human Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


GSK
Biovac
McKesson Medical
Merck
Merial
Zoetis
Sanofi
Segment by Type
Inactivated Vaccine
Attenuated Vaccine
Others

Segment by Application


Hospital
Scientific Research
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Prophylactic Human Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Prophylactic Human Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Prophylactic Human Vaccine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Prophylactic Human Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Prophylactic Human Vaccine introduction, etc. Prophylactic Human Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Prophylactic Human Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Prophylactic Human Vaccine Market Overview
1.1 Prophylactic Human Vaccine Product Overview
1.2 Prophylactic Human Vaccine Market Segment by Type
1.2.1 Inactivated Vaccine
1.2.2 Attenuated Vaccine
1.2.3 Others
1.3 Global Prophylactic Human Vaccine Market Size by Type
1.3.1 Global Prophylactic Human Vaccine Market Size Overview by Type (2018-2034)
1.3.2 Global Prophylactic Human Vaccine Historic Market Size Review by Type (2018-2024)
1.3.3 Global Prophylactic Human Vaccine Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Prophylactic Human Vaccine Sales Breakdown by Type (2018-2024)
1.4.2 Europe Prophylactic Human Vaccine Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Prophylactic Human Vaccine Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Prophylactic Human Vaccine Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Prophylactic Human Vaccine Sales Breakdown by Type (2018-2024)
2 Global Prophylactic Human Vaccine Market Competition by Company
2.1 Global Top Players by Prophylactic Human Vaccine Sales (2018-2024)
2.2 Global Top Players by Prophylactic Human Vaccine Revenue (2018-2024)
2.3 Global Top Players by Prophylactic Human Vaccine Price (2018-2024)
2.4 Global Top Manufacturers Prophylactic Human Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Prophylactic Human Vaccine Market Competitive Situation and Trends
2.5.1 Prophylactic Human Vaccine Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Prophylactic Human Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Prophylactic Human Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Prophylactic Human Vaccine Market
2.8 Key Manufacturers Prophylactic Human Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Prophylactic Human Vaccine Status and Outlook by Region
3.1 Global Prophylactic Human Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Prophylactic Human Vaccine Historic Market Size by Region
3.2.1 Global Prophylactic Human Vaccine Sales in Volume by Region (2018-2024)
3.2.2 Global Prophylactic Human Vaccine Sales in Value by Region (2018-2024)
3.2.3 Global Prophylactic Human Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Prophylactic Human Vaccine Forecasted Market Size by Region
3.3.1 Global Prophylactic Human Vaccine Sales in Volume by Region (2024-2034)
3.3.2 Global Prophylactic Human Vaccine Sales in Value by Region (2024-2034)
3.3.3 Global Prophylactic Human Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Prophylactic Human Vaccine by Application
4.1 Prophylactic Human Vaccine Market Segment by Application
4.1.1 Hospital
4.1.2 Scientific Research
4.1.3 Others
4.2 Global Prophylactic Human Vaccine Market Size by Application
4.2.1 Global Prophylactic Human Vaccine Market Size Overview by Application (2018-2034)
4.2.2 Global Prophylactic Human Vaccine Historic Market Size Review by Application (2018-2024)
4.2.3 Global Prophylactic Human Vaccine Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Prophylactic Human Vaccine Sales Breakdown by Application (2018-2024)
4.3.2 Europe Prophylactic Human Vaccine Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Prophylactic Human Vaccine Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Prophylactic Human Vaccine Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Prophylactic Human Vaccine Sales Breakdown by Application (2018-2024)
5 North America Prophylactic Human Vaccine by Country
5.1 North America Prophylactic Human Vaccine Historic Market Size by Country
5.1.1 North America Prophylactic Human Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Prophylactic Human Vaccine Sales in Volume by Country (2018-2024)
5.1.3 North America Prophylactic Human Vaccine Sales in Value by Country (2018-2024)
5.2 North America Prophylactic Human Vaccine Forecasted Market Size by Country
5.2.1 North America Prophylactic Human Vaccine Sales in Volume by Country (2024-2034)
5.2.2 North America Prophylactic Human Vaccine Sales in Value by Country (2024-2034)
6 Europe Prophylactic Human Vaccine by Country
6.1 Europe Prophylactic Human Vaccine Historic Market Size by Country
6.1.1 Europe Prophylactic Human Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Prophylactic Human Vaccine Sales in Volume by Country (2018-2024)
6.1.3 Europe Prophylactic Human Vaccine Sales in Value by Country (2018-2024)
6.2 Europe Prophylactic Human Vaccine Forecasted Market Size by Country
6.2.1 Europe Prophylactic Human Vaccine Sales in Volume by Country (2024-2034)
6.2.2 Europe Prophylactic Human Vaccine Sales in Value by Country (2024-2034)
7 Asia-Pacific Prophylactic Human Vaccine by Region
7.1 Asia-Pacific Prophylactic Human Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Prophylactic Human Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Prophylactic Human Vaccine Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Prophylactic Human Vaccine Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Prophylactic Human Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Prophylactic Human Vaccine Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Prophylactic Human Vaccine Sales in Value by Region (2024-2034)
8 Latin America Prophylactic Human Vaccine by Country
8.1 Latin America Prophylactic Human Vaccine Historic Market Size by Country
8.1.1 Latin America Prophylactic Human Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Prophylactic Human Vaccine Sales in Volume by Country (2018-2024)
8.1.3 Latin America Prophylactic Human Vaccine Sales in Value by Country (2018-2024)
8.2 Latin America Prophylactic Human Vaccine Forecasted Market Size by Country
8.2.1 Latin America Prophylactic Human Vaccine Sales in Volume by Country (2024-2034)
8.2.2 Latin America Prophylactic Human Vaccine Sales in Value by Country (2024-2034)
9 Middle East and Africa Prophylactic Human Vaccine by Country
9.1 Middle East and Africa Prophylactic Human Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Prophylactic Human Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Prophylactic Human Vaccine Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Prophylactic Human Vaccine Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Prophylactic Human Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Prophylactic Human Vaccine Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Prophylactic Human Vaccine Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 GSK
10.1.1 GSK Company Information
10.1.2 GSK Introduction and Business Overview
10.1.3 GSK Prophylactic Human Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.1.4 GSK Prophylactic Human Vaccine Products Offered
10.1.5 GSK Recent Development
10.2 Biovac
10.2.1 Biovac Company Information
10.2.2 Biovac Introduction and Business Overview
10.2.3 Biovac Prophylactic Human Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Biovac Prophylactic Human Vaccine Products Offered
10.2.5 Biovac Recent Development
10.3 McKesson Medical
10.3.1 McKesson Medical Company Information
10.3.2 McKesson Medical Introduction and Business Overview
10.3.3 McKesson Medical Prophylactic Human Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.3.4 McKesson Medical Prophylactic Human Vaccine Products Offered
10.3.5 McKesson Medical Recent Development
10.4 Merck
10.4.1 Merck Company Information
10.4.2 Merck Introduction and Business Overview
10.4.3 Merck Prophylactic Human Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Merck Prophylactic Human Vaccine Products Offered
10.4.5 Merck Recent Development
10.5 Merial
10.5.1 Merial Company Information
10.5.2 Merial Introduction and Business Overview
10.5.3 Merial Prophylactic Human Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Merial Prophylactic Human Vaccine Products Offered
10.5.5 Merial Recent Development
10.6 Zoetis
10.6.1 Zoetis Company Information
10.6.2 Zoetis Introduction and Business Overview
10.6.3 Zoetis Prophylactic Human Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Zoetis Prophylactic Human Vaccine Products Offered
10.6.5 Zoetis Recent Development
10.7 Sanofi
10.7.1 Sanofi Company Information
10.7.2 Sanofi Introduction and Business Overview
10.7.3 Sanofi Prophylactic Human Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Sanofi Prophylactic Human Vaccine Products Offered
10.7.5 Sanofi Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Prophylactic Human Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Prophylactic Human Vaccine Industrial Chain Analysis
11.4 Prophylactic Human Vaccine Market Dynamics
11.4.1 Prophylactic Human Vaccine Industry Trends
11.4.2 Prophylactic Human Vaccine Market Drivers
11.4.3 Prophylactic Human Vaccine Market Challenges
11.4.4 Prophylactic Human Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Prophylactic Human Vaccine Distributors
12.3 Prophylactic Human Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Inactivated Vaccine
Table 2. Major Company of Attenuated Vaccine
Table 3. Major Company of Others
Table 4. Global Prophylactic Human Vaccine Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Prophylactic Human Vaccine Sales by Type (2018-2024) & (K Units)
Table 6. Global Prophylactic Human Vaccine Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Prophylactic Human Vaccine Sales by Type (2018-2024) & (US& Million)
Table 8. Global Prophylactic Human Vaccine Market Share in Value by Type (2018-2024)
Table 9. Global Prophylactic Human Vaccine Price by Type (2018-2024) & (USD/Unit)
Table 10. Global Prophylactic Human Vaccine Sales by Type (2024-2034) & (K Units)
Table 11. Global Prophylactic Human Vaccine Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Prophylactic Human Vaccine Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Prophylactic Human Vaccine Sales Market Share in Value by Type (2024-2034)
Table 14. Global Prophylactic Human Vaccine Price by Type (2024-2034) & (USD/Unit)
Table 15. North America Prophylactic Human Vaccine Sales by Type (2018-2024) & (K Units)
Table 16. North America Prophylactic Human Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Prophylactic Human Vaccine Sales (K Units) by Type (2018-2024)
Table 18. Europe Prophylactic Human Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Prophylactic Human Vaccine Sales (K Units) by Type (2018-2024)
Table 20. Asia-Pacific Prophylactic Human Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Prophylactic Human Vaccine Sales (K Units) by Type (2018-2024)
Table 22. Latin America Prophylactic Human Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Prophylactic Human Vaccine Sales (K Units) by Type (2018-2024)
Table 24. Middle East and Africa Prophylactic Human Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Prophylactic Human Vaccine Sales by Company (2018-2024) & (K Units)
Table 26. Global Prophylactic Human Vaccine Sales Share by Company (2018-2024)
Table 27. Global Prophylactic Human Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Prophylactic Human Vaccine Revenue Share by Company (2018-2024)
Table 29. Global Market Prophylactic Human Vaccine Price by Company (2018-2024) & (USD/Unit)
Table 30. Global Prophylactic Human Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Prophylactic Human Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Prophylactic Human Vaccine as of 2022)
Table 33. Date of Key Manufacturers Enter into Prophylactic Human Vaccine Market
Table 34. Key Manufacturers Prophylactic Human Vaccine Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Prophylactic Human Vaccine Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 37. Global Prophylactic Human Vaccine Sales by Region (2018-2024) & (K Units)
Table 38. Global Prophylactic Human Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Prophylactic Human Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Prophylactic Human Vaccine Sales Market Share in Value by Region (2018-2024)
Table 41. Global Prophylactic Human Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 42. Global Prophylactic Human Vaccine Sales by Region (2024-2034) & (K Units)
Table 43. Global Prophylactic Human Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Prophylactic Human Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Prophylactic Human Vaccine Sales Market Share in Value by Region (2024-2034)
Table 46. Global Prophylactic Human Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 47. Global Prophylactic Human Vaccine Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 48. Global Prophylactic Human Vaccine Sales by Application (2018-2024) & (K Units)
Table 49. Global Prophylactic Human Vaccine Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Prophylactic Human Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Prophylactic Human Vaccine Sales Market Share in Value by Application (2018-2024)
Table 52. Global Prophylactic Human Vaccine Price by Application (2018-2024) & (USD/Unit)
Table 53. Global Prophylactic Human Vaccine Sales by Application (2024-2034) & (K Units)
Table 54. Global Prophylactic Human Vaccine Sales Market Share in Volume by Application (2024-2034)
Table 55. Global Prophylactic Human Vaccine Sales by Application (2024-2034) & (US$ Million)
Table 56. Global Prophylactic Human Vaccine Sales Market Share in Value by Application (2024-2034)
Table 57. Global Prophylactic Human Vaccine Price by Application (2024-2034) & (USD/Unit)
Table 58. North America Prophylactic Human Vaccine Sales by Application (2018-2024) (K Units)
Table 59. North America Prophylactic Human Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Prophylactic Human Vaccine Sales by Application (2018-2024) (K Units)
Table 61. Europe Prophylactic Human Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Prophylactic Human Vaccine Sales by Application (2018-2024) (K Units)
Table 63. Asia-Pacific Prophylactic Human Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Prophylactic Human Vaccine Sales by Application (2018-2024) (K Units)
Table 65. Latin America Prophylactic Human Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Prophylactic Human Vaccine Sales by Application (2018-2024) (K Units)
Table 67. Middle East and Africa Prophylactic Human Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Prophylactic Human Vaccine Sales by Country (2018-2024) & (K Units)
Table 69. North America Prophylactic Human Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Prophylactic Human Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Prophylactic Human Vaccine Sales Market Share in Value by Country (2018-2024)
Table 72. North America Prophylactic Human Vaccine Sales by Country (2024-2034) & (K Units)
Table 73. North America Prophylactic Human Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Prophylactic Human Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Prophylactic Human Vaccine Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Prophylactic Human Vaccine Sales by Country (2018-2024) & (K Units)
Table 77. Europe Prophylactic Human Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Prophylactic Human Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Prophylactic Human Vaccine Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Prophylactic Human Vaccine Sales by Country (2024-2034) & (K Units)
Table 81. Europe Prophylactic Human Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Prophylactic Human Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Prophylactic Human Vaccine Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Prophylactic Human Vaccine Sales by Region (2018-2024) & (K Units)
Table 85. Asia-Pacific Prophylactic Human Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Prophylactic Human Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Prophylactic Human Vaccine Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Prophylactic Human Vaccine Sales by Region (2024-2034) & (K Units)
Table 89. Asia-Pacific Prophylactic Human Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Prophylactic Human Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Prophylactic Human Vaccine Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Prophylactic Human Vaccine Sales by Country (2018-2024) & (K Units)
Table 93. Latin America Prophylactic Human Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Prophylactic Human Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Prophylactic Human Vaccine Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Prophylactic Human Vaccine Sales by Country (2024-2034) & (K Units)
Table 97. Latin America Prophylactic Human Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Prophylactic Human Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Prophylactic Human Vaccine Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Prophylactic Human Vaccine Sales by Country (2018-2024) & (K Units)
Table 101. Middle East and Africa Prophylactic Human Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Prophylactic Human Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Prophylactic Human Vaccine Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Prophylactic Human Vaccine Sales by Country (2024-2034) & (K Units)
Table 105. Middle East and Africa Prophylactic Human Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Prophylactic Human Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Prophylactic Human Vaccine Sales Market Share in Value by Country (2024-2034)
Table 108. GSK Company Information
Table 109. GSK Introduction and Business Overview
Table 110. GSK Prophylactic Human Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 111. GSK Prophylactic Human Vaccine Product
Table 112. GSK Recent Development
Table 113. Biovac Company Information
Table 114. Biovac Introduction and Business Overview
Table 115. Biovac Prophylactic Human Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 116. Biovac Prophylactic Human Vaccine Product
Table 117. Biovac Recent Development
Table 118. McKesson Medical Company Information
Table 119. McKesson Medical Introduction and Business Overview
Table 120. McKesson Medical Prophylactic Human Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 121. McKesson Medical Prophylactic Human Vaccine Product
Table 122. McKesson Medical Recent Development
Table 123. Merck Company Information
Table 124. Merck Introduction and Business Overview
Table 125. Merck Prophylactic Human Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 126. Merck Prophylactic Human Vaccine Product
Table 127. Merck Recent Development
Table 128. Merial Company Information
Table 129. Merial Introduction and Business Overview
Table 130. Merial Prophylactic Human Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 131. Merial Prophylactic Human Vaccine Product
Table 132. Merial Recent Development
Table 133. Zoetis Company Information
Table 134. Zoetis Introduction and Business Overview
Table 135. Zoetis Prophylactic Human Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 136. Zoetis Prophylactic Human Vaccine Product
Table 137. Zoetis Recent Development
Table 138. Sanofi Company Information
Table 139. Sanofi Introduction and Business Overview
Table 140. Sanofi Prophylactic Human Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 141. Sanofi Prophylactic Human Vaccine Product
Table 142. Sanofi Recent Development
Table 143. Key Raw Materials Lists
Table 144. Raw Materials Key Suppliers Lists
Table 145. Prophylactic Human Vaccine Market Trends
Table 146. Prophylactic Human Vaccine Market Drivers
Table 147. Prophylactic Human Vaccine Market Challenges
Table 148. Prophylactic Human Vaccine Market Restraints
Table 149. Prophylactic Human Vaccine Distributors List
Table 150. Prophylactic Human Vaccine Downstream Customers
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Prophylactic Human Vaccine Product Picture
Figure 2. Global Prophylactic Human Vaccine Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Prophylactic Human Vaccine Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Prophylactic Human Vaccine Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Inactivated Vaccine
Figure 6. Global Inactivated Vaccine Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Attenuated Vaccine
Figure 8. Global Attenuated Vaccine Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of Others
Figure 10. Global Others Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Global Prophylactic Human Vaccine Sales by Type (2018-2034) & (US$ Million)
Figure 12. Global Prophylactic Human Vaccine Sales Market Share by Type in 2022 & 2034
Figure 13. North America Prophylactic Human Vaccine Sales Market Share in Volume by Type in 2022
Figure 14. North America Prophylactic Human Vaccine Sales Market Share in Value by Type in 2022
Figure 15. Europe Prophylactic Human Vaccine Sales Market Share in Volume by Type in 2022
Figure 16. Europe Prophylactic Human Vaccine Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Prophylactic Human Vaccine Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Prophylactic Human Vaccine Sales Market Share in Value by Type in 2022
Figure 19. Latin America Prophylactic Human Vaccine Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Prophylactic Human Vaccine Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Prophylactic Human Vaccine Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Prophylactic Human Vaccine Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Prophylactic Human Vaccine Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Prophylactic Human Vaccine Revenue in 2022
Figure 25. Prophylactic Human Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Hospital
Figure 27. Global Hospital Sales YoY Growth (2018-2034) & (K Units)
Figure 28. Product Picture of Scientific Research
Figure 29. Global Scientific Research Sales YoY Growth (2018-2034) & (K Units)
Figure 30. Product Picture of Others
Figure 31. Global Others Sales YoY Growth (2018-2034) & (K Units)
Figure 32. Global Prophylactic Human Vaccine Sales by Application (2018-2034) & (US$ Million)
Figure 33. Global Prophylactic Human Vaccine Sales Market Share by Application in 2022 & 2034
Figure 34. North America Prophylactic Human Vaccine Sales Market Share in Volume by Application in 2022
Figure 35. North America Prophylactic Human Vaccine Sales Market Share in Value by Application in 2022
Figure 36. Europe Prophylactic Human Vaccine Sales Market Share in Volume by Application in 2022
Figure 37. Europe Prophylactic Human Vaccine Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Prophylactic Human Vaccine Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Prophylactic Human Vaccine Sales Market Share in Value by Application in 2022
Figure 40. Latin America Prophylactic Human Vaccine Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Prophylactic Human Vaccine Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Prophylactic Human Vaccine Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Prophylactic Human Vaccine Manufacturing Cost Structure
Figure 45. Prophylactic Human Vaccine Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries